Literature DB >> 1820687

Developmental control by the Drosophila EGF receptor homolog DER.

B Z Shilo1, E Raz.   

Abstract

The identification of receptor tyrosine kinases in Drosophila has provided an opportunity to study the requirement for these proteins during the development of a multicellular organism. Genetic analysis of the function of the Drosophila epidermal growth factor (EGF) receptor homolog (DER) has revealed an extremely diverse set of roles for this protein throughout the life cycle of the organism, for example in eye development and in the establishment of dorsoventral polarity in the oocyte. We discuss the possible basis for the pleiotropic activity of DER, and the similarities and differences in the function of the homologous proteins in other invertebrates and vertebrates.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1820687     DOI: 10.1016/0168-9525(91)90261-n

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  4 in total

1.  Genetic analysis of rolled, which encodes a Drosophila mitogen-activated protein kinase.

Authors:  Y M Lim; K Nishizawa; Y Nishi; L Tsuda; Y H Inoue; Y Nishida
Journal:  Genetics       Date:  1999-10       Impact factor: 4.562

2.  The human GRB2 and Drosophila Drk genes can functionally replace the Caenorhabditis elegans cell signaling gene sem-5.

Authors:  M J Stern; L E Marengere; R J Daly; E J Lowenstein; M Kokel; A Batzer; P Olivier; T Pawson; J Schlessinger
Journal:  Mol Biol Cell       Date:  1993-11       Impact factor: 4.138

3.  Split ends antagonizes the Notch and potentiates the EGFR signaling pathways during Drosophila eye development.

Authors:  David B Doroquez; Terry L Orr-Weaver; Ilaria Rebay
Journal:  Mech Dev       Date:  2007-05-21       Impact factor: 1.882

4.  Fly-QMA: Automated analysis of mosaic imaginal discs in Drosophila.

Authors:  Sebastian M Bernasek; Nicolás Peláez; Richard W Carthew; Neda Bagheri; Luís A N Amaral
Journal:  PLoS Comput Biol       Date:  2020-03-03       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.